Updates are available Erratum dated 2017-11-08

Article History

First Online: 17 October 2017

Change Date: 8 November 2017

Change Type: Correction

Change Details: In the version of this Review published online ahead of print, The Acknowledgements section in the online and PDF versions of this manuscript originally contained the text "The authors gratefully acknowledge financial support from the Prostate Cancer Clinical Trials Consortium of the Prostate Cancer Foundation, and a SPORE Center Grant to the Sidney Kimmel Center for Prostate and Urologic Cancers." This was incorrect and has been corrected to "The authors gratefully acknowledge financial support from the Department of Defense Prostate Cancer Research Program (PC121111 and PC131984), the NIH/NCI (Cancer Center Support Grant P30-CA008748, P50-CA92629 SPORE in Prostate Cancer), the Prostate Cancer Foundation, and the Sidney Kimmel Center for Prostate and Urologic Cancers” in the online and PDF versions of this manuscript.

Competing interests

: H.I.S. declares that he is a member of the board of directors of Asterias Biotherapeutics, has served as a compensated consultant of Blue Earth Diagnostics, Sanofi Aventis, and WCG Oncology, and has served as an uncompensated consultant of Ferring Pharmaceuticals, Janssen Research & Development, LLC and Medivation. M.Y.T., M.J.O., S.M.M. and H.A.V. declare no competing interests.